111 related articles for article (PubMed ID: 8839660)
1. A drug interaction study between cicletanine and tolbutamide in healthy volunteers.
Bayés MC; Barbanoj MJ; Vallès J; Torrent J; Obach R; Jané F
Eur J Clin Pharmacol; 1996; 50(5):381-4. PubMed ID: 8839660
[TBL] [Abstract][Full Text] [Related]
2. [Serum immunoreactive insulin after the oral administration of single dose of tolbutamide. I. Peripheral vein immunoreactive insulin in normal subjects and mild diabetics (author's transl)].
Goto A
Nihon Naibunpi Gakkai Zasshi; 1975 Aug; 51(8):676-84. PubMed ID: 1237421
[TBL] [Abstract][Full Text] [Related]
3. [Serum immunoreactive insulin after the oral administration of single dose of tolbutamide. II. Pancreatic vein immunoreactive insulin in dogs (author's transl)].
Goto A
Nihon Naibunpi Gakkai Zasshi; 1975 Aug; 51(8):685-92. PubMed ID: 1237422
[TBL] [Abstract][Full Text] [Related]
4. Dynamics of tolbutamide, glucose, and insulin interrelationships following varying doses of intravenous tolbutamide in normal subjects.
Ganda OP; Kahn CB; Soeldner JS; Gleason RE
Diabetes; 1975 Apr; 24(4):354-67. PubMed ID: 1132601
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic interaction between diltiazem and tolbutamide.
Dixit AA; Rao YM
Drug Metabol Drug Interact; 1999; 15(4):269-77. PubMed ID: 10716041
[TBL] [Abstract][Full Text] [Related]
6. Similar physiological and symptomatic responses to sulphonylurea and insulin induced hypoglycaemia in normal subjects.
Peacey SR; George E; Rostami-Hodjegan A; Bedford C; Harris N; Hardisty CA; Tucker GT; Macdonald IA; Heller SR
Diabet Med; 1996 Jul; 13(7):634-41. PubMed ID: 8840097
[TBL] [Abstract][Full Text] [Related]
7. Lack of interaction between fluvastatin and oral hypoglycemic agents in healthy subjects and in patients with non-insulin-dependent diabetes mellitus.
Appel S; Rüfenacht T; Kalafsky G; Tetzloff W; Kallay Z; Hitzenberger G; Kutz K
Am J Cardiol; 1995 Jul; 76(2):29A-32A. PubMed ID: 7604792
[TBL] [Abstract][Full Text] [Related]
8. Renal hemodynamics and sodium excretion after acute and chronic administration of cicletanine in normotensive and hypertensive subjects.
Moulin B; Fillastre JP; Godin M; Coquerel A; Decoopman E
J Cardiovasc Pharmacol; 1995 Feb; 25(2):292-9. PubMed ID: 7752655
[TBL] [Abstract][Full Text] [Related]
9. Effect of cicletanine on renal cGMP production.
Valdivielso JM; Morales AI; Pérez-Barriocanal F; López-Novoa JM
Can J Physiol Pharmacol; 1998 Dec; 76(12):1151-5. PubMed ID: 10326838
[TBL] [Abstract][Full Text] [Related]
10. Preserved insulin response to tolbutamide in hepatocyte nuclear factor-1alpha mutation carriers.
Sagen JV; Pearson ER; Johansen A; Spyer G; Søvik O; Pedersen O; Njølstad PR; Hattersley AT; Hansen T
Diabet Med; 2005 Apr; 22(4):406-9. PubMed ID: 15787664
[TBL] [Abstract][Full Text] [Related]
11. [Insulin-stimulating properties of Glybenclamide (HB 419) in healthy subjects. Comparative studies with tolbutamide].
Brunetti P; Cozzolino G; Santeusanio F; Arena D; De Ciuceis P; Marri G; Migliorini E
Acta Diabetol Lat; 1969; 6(2):283-98. PubMed ID: 5397408
[No Abstract] [Full Text] [Related]
12. [Improvement in glucose tolerance and insulin sensitivity after a single administration of tolbutamide in hypertensive patients].
Dzúrik R; Dzúriková K; Spustová V
Vnitr Lek; 1991 Mar; 37(3):255-60. PubMed ID: 2031314
[TBL] [Abstract][Full Text] [Related]
13. Response of plasma insulin to small doses of tolbutamide in obesity and acromegaly.
Pelkonen R; Taskinen MR; Nikkilä EA
Int J Obes; 1977; 1(4):315-24. PubMed ID: 617112
[TBL] [Abstract][Full Text] [Related]
14. Craniopharyngioma: the role of insulin in promoting postoperative growth.
Costin G; Kogut MD; Phillips LS; Daughaday WH
J Clin Endocrinol Metab; 1976 Feb; 42(2):370-9. PubMed ID: 1262435
[TBL] [Abstract][Full Text] [Related]
15. Interaction between tolbutamide and ketoconazole in healthy subjects.
Krishnaiah YS; Satyanarayana S; Visweswaram D
Br J Clin Pharmacol; 1994 Feb; 37(2):205-7. PubMed ID: 8186066
[TBL] [Abstract][Full Text] [Related]
16. Tolbutamide causes a modest increase in insulin secretion in cystic fibrosis patients with impaired glucose tolerance.
Hinds A; Sheehan AG; Parsons HG
Metabolism; 1995 Jan; 44(1):13-8. PubMed ID: 7854158
[TBL] [Abstract][Full Text] [Related]
17. Effects of Ginkgo biloba extract on pharmacokinetics and pharmacodynamics of tolbutamide and midazolam in healthy volunteers.
Uchida S; Yamada H; Li XD; Maruyama S; Ohmori Y; Oki T; Watanabe H; Umegaki K; Ohashi K; Yamada S
J Clin Pharmacol; 2006 Nov; 46(11):1290-8. PubMed ID: 17050793
[TBL] [Abstract][Full Text] [Related]
18. Plasma insulin, C-peptide, and blood glucose in portal, hepatic and peripheral veins in liver cirrhosis. Effect of intravenous tolbutamide.
Pelkonen R; Kallio H; Suoranta H; Karonen SL
Acta Endocrinol (Copenh); 1981 Aug; 97(4):496-502. PubMed ID: 7023164
[TBL] [Abstract][Full Text] [Related]
19. Multiple dose pharmacokinetic study of cicletanine in healthy volunteers.
Peraire C; Torrent J; Pruñonosa J; Azcona O; Nomen M; Obach R
Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():173-7. PubMed ID: 1820874
[TBL] [Abstract][Full Text] [Related]
20. [Changes in the glucose tolerance parameters in non-diabetic hypertensive patients treated with cicletanine].
Clerson P; Carre A; Berthet P; Deltour L; Billaut P; Debeaumont D; Tarrade T; Lefebvre J
Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():139-43. PubMed ID: 2514654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
